⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Active Pharmaceutical Ingredients (API) Market Report 2026-2036 Just Released — Analyses Synthetic, Biotech, Traditional and Highly Potent APIs
globenewswire.com
MRK
PFE
NVS
Kynexis Extends Series A to €97 Million to Advance Potential First-in-Class Investigational Medicine for Cognitive Disorders
globenewswire.com
NVS
Vulvar Cancer Therapeutics Market Share Analysis, Trends and Growth Forecast 2026-2031
globenewswire.com
ABBV
AMGN
AZN
BMY
LLY
GSK
JNJ
MRK
NVS
PDSB
PFE
SNY
Novartis data at ESC Congress 2026 reinforce cardiovascular leadership and showcase progress in next-generation therapies
globenewswire.com
NVS
Trends & Strategies in the $4.3 Billion Soft Tissue Sarcoma Market, 2026-2031
globenewswire.com
AZN
BMY
LLY
GSK
ILMN
MRK
NVS
PFE
QGEN
SNY
VTRS
OncoOne Establishes Scientific Advisory Board to Support its Modular PreTarg-it® Platform for Radionuclide Therapies
businesswire.com
TLX
BIIB
NVS
BMY
Registration Open for 3-Day "Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success" Virtual Seminar (Jan 25th - Jan 27th, 2027)
globenewswire.com
GSK
NVS
Acute Lymphoblastic Leukemia (ALL) Therapeutics Market Report 2026-2031 - Growth Sustained by Continued Clinical Innovation, Improving Pediatric Survival Outcomes and Broader MRD Adoption
globenewswire.com
AMGN
JAZZ
NVS
PFE
JNJ
GILD
MRK
ABBV
Global Fusion Biopsy Market to Register Sustainable Growth at a CAGR of ~6% by 2034 | DelveInsight
globenewswire.com
BSX
CAH
MDT
GEHC
XRAY
AMGN
AZN
BMY
LLY
MRK
PFE
SNY
TEVA
JNJ
BIIB
GILD
NVS
GOOG
MSFT
IBM
NVDA
INTC
AMD
QCOM
AMAT
MU
NXPI
ASML
ADI
LRCX
KLAC
CDNS
SNPS
MCHP
ON
STM
MRVL
AEHR
TER
PAYX
CTAS
WST
ZBRA
VRSN
NOW
CRM
ADBE
PANW
CSCO
ACN
HPQ
ORCL
SAP
PTC
ALGN
ESTC
DDOG
SMCI
EXAS
CRSP
EDIT
BEAM
NTLA
REGN
VRTX
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
IQ
BILI
VIPS
HTHT
EDU
TAL
MELI
AMZN
NFLX
DIS
CMCSA
VZ
T
SIRI
GOOGL
AAPL
META
TSLA
GE
PHI
BRKR
AUR
FONR
BFLY
CRI
EXEL
TAK
ABSI
JHG
XNCR
MOD
ARVN
CLAR
BNTX
FOR
ORIC
COOK
OWL
MTA
SKIN
HYPR
ALLT
MAGN
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Grow Significantly at a CAGR of 6.8% During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Pipeline | DelveInsight
prnewswire.com
CLLS
AUTL
FATE
GILD
NVS